Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus.

Vascular health and risk management - 1 Jan 2011

Olusi Samuel O, George Sunila

Abstract excerpt

BACKGROUND: Patients with systemic lupus erythematosus (SLE) are 5-8 times more likely to develop coronary heart disease than the general population. The aim of this study was to find out the prevalence of the small dense low-density lipoprotein (LDL) cholesterol particle in patients with SLE. METHODS: We recruited 50 consecutive patients with SLE who had no evidence of hypertension or renal failure. Fifty age-...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Atherosclerosis
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Kuwait

Share to Lupus Erythematosus, Systemic

Share to Particle Size

Source

Open in PubMed Open full text

Identifiers

PMID: 21415920
DOI: 10.2147/VHRM.S17015
PMCID: PMC3049542

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus.PMID 21415920Read ↗

Asymptomatic Carotid Atherosclerosis Cardiovascular Risk Factors and Common Hypertriglyceridemia Genetic Variants in Patients with Systemic Erythematosus LupusSemantic proximity Read ↗

Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases.Semantic proximity Read ↗

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read ↗

An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus.Semantic proximity Read ↗

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.Semantic proximity Read ↗

Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.Semantic proximity Read ↗

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.Semantic proximity Read ↗

Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus.Semantic proximity Read ↗

LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease.Semantic proximity Read ↗

Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.Semantic proximity Read ↗

LDL size: does it matter?Semantic proximity Read ↗

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.